Reducing Tobacco Smoking: a Transcranial Direct Current Stimulation (TDCS) Telehealth Study

Description

The study aims to evaluate the feasibility of using Dorsolateral Prefrontal Cortex (DLPFC) Transcranial Direct Current Stimulation (tDCS) as a tool to decreasing distress and cigarette smoking. 46 participants currently smoking cigarettes, and seeking to decrease cigarette use will be recruited.

Conditions

Smoking Cessation

Talk to us

Study Overview

On this page

Study Details

Study overview

The study aims to evaluate the feasibility of using Dorsolateral Prefrontal Cortex (DLPFC) Transcranial Direct Current Stimulation (tDCS) as a tool to decreasing distress and cigarette smoking. 46 participants currently smoking cigarettes, and seeking to decrease cigarette use will be recruited.

Reducing Distress and Tobacco Smoking in Cancer Survivors: a TDCS Telehealth Study

Reducing Tobacco Smoking: a Transcranial Direct Current Stimulation (TDCS) Telehealth Study

Condition
Smoking Cessation
Intervention / Treatment

-

Contacts and Locations

Winston-Salem

Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States, 27157

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 21-75 years old
  • * smoke ≥10 cigarettes per day
  • * mild to moderate distress (K10 scores 10-35)
  • * access to a reliable internet connection
  • * all prescription medications stable for ≥ 1 month prior to enrollment and throughout the trial, and approved by the Study Physician
  • * Current suicidal ideation
  • * Current use of smoking cessation medication (e.g., varenicline)
  • * Current use of inhaled products (other than cigarettes) which may influence exhaled carbon monoxide measures (e.g. smoking cannabis, vaping)
  • * History of seizure disorder, recent (\<5 years) seizure history, cerebrovascular accident, neurodegenerative disease, or traumatic brain injury
  • * Currently receiving chemotherapy or radiation
  • * Presence of metal objects in the head/neck
  • * Any skin disorder or skin sensitive area near stimulation locations

Ages Eligible for Study

21 Years to 75 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Wake Forest University Health Sciences,

Merideth A Addicott, Ph.D., PRINCIPAL_INVESTIGATOR, Wake Forest University Health Sciences

Study Record Dates

2025-01